<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD with OASIS Tables v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing-oasis-article1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharm Biol</journal-id><journal-id journal-id-type="iso-abbrev">Pharm Biol</journal-id><journal-id journal-id-type="publisher-id">IPHB</journal-id><journal-id journal-id-type="publisher-id">iphb20</journal-id><journal-title-group><journal-title>Pharmaceutical Biology</journal-title></journal-title-group><issn pub-type="ppub">1388-0209</issn><issn pub-type="epub">1744-5116</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6508049</article-id><article-id pub-id-type="doi">10.1080/13880209.2019.1606836</article-id><article-id pub-id-type="publisher-id">1606836</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Methanol extract of <italic>Muntingia calabura</italic> leaves attenuates CCl<sub>4</sub>-induced liver injury: possible synergistic action of flavonoids and volatile bioactive compounds on endogenous defence system</article-title><alt-title alt-title-type="running-authors">Z. A. Zakaria et al.</alt-title><alt-title alt-title-type="running-title"><italic>M. calabura</italic> attenuates CCl4-induced liver toxicity</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5525-7821</contrib-id><name><surname>Zakaria</surname><given-names>Zainul Amiruddin</given-names></name><xref ref-type="aff" rid="AF0001"><sup>a</sup></xref><xref ref-type="aff" rid="AF0002"><sup>b</sup></xref><xref ref-type="aff" rid="AF0003"><sup>c</sup></xref><xref ref-type="corresp" rid="AN0001"/></contrib><contrib contrib-type="author"><name><surname>Mahmood</surname><given-names>Nur Diyana</given-names></name><xref ref-type="aff" rid="AF0003"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Omar</surname><given-names>Maizatul Hasyima</given-names></name><xref ref-type="aff" rid="AF0004"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Taher</surname><given-names>Muhammad</given-names></name><xref ref-type="aff" rid="AF0005"><sup>e</sup></xref></contrib><contrib contrib-type="author"><name><surname>Basir</surname><given-names>Rusliza</given-names></name><xref ref-type="aff" rid="AF0006"><sup>f</sup></xref></contrib><aff id="AF0001"><label>a</label><institution>Laboratory of Halal Science Research, Halal Products Research Institute, Universiti Putra Malaysia</institution>, Serdang, <country>Malaysia</country>; </aff><aff id="AF0002"><label>b</label><institution>Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA</institution>, Puncak Alam, <country>Malaysia</country>; </aff><aff id="AF0003"><label>c</label><institution>Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia</institution>, Serdang, <country>Malaysia</country>; </aff><aff id="AF0004"><label>d</label><institution>Phytochemistry Unit Herbal Medicine Research Centre, Institute for Medical Research</institution>, Kuala Lumpur, <country>Malaysia</country>; </aff><aff id="AF0005"><label>e</label><institution>Department of Pharmaceutical Technology, Kulliyah of Pharmacy International Islamic University Malaysia</institution>, Kuantan, <country>Malaysia</country>; </aff><aff id="AF0006"><label>f</label><institution>Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia</institution>, Serdang, <country>Malaysia</country></aff></contrib-group><author-notes><corresp id="AN0001">CONTACT Zainul Amiruddin Zakaria <email>drzazakaria@gmail.com</email>, <email>zaz@upm.edu.my</email><institution>Department of Biomedical Science, Faculty of Medicine and Health Science, Universiti Putra Malaysia</institution>, 43400<addr-line>UPM Serdang</addr-line>, Serdang, Selangor, <country>Malaysia</country>.</corresp></author-notes><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>08</day><month>5</month><year>2019</year></pub-date><volume>57</volume><issue>1</issue><fpage seq="42">335</fpage><lpage>344</lpage><history><date date-type="received"><day>24</day><month>10</month><year>2018</year></date><date date-type="rev-recd"><day>09</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>08</day><month>4</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 The Author(s). Published by Informa UK Limited, trading as Taylor &#x00026; Francis Group.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="iphb-57-1606836.pdf"/><abstract><title>Abstract</title><p><bold>Context:</bold><italic>Muntingia calabura</italic> L. (Muntingiaceae) exerts antioxidant and anti-inflammatory activities, thus, it might be a good hepatoprotective agent.</p><p><bold>Objective:</bold> This study investigates the effect of methanol extract of <italic>M. calabura</italic> leaves (MMCL) on hepatic antioxidant and anti-inflammatory activities in CCl<sub>4</sub>-induced hepatotoxic rat.</p><p><bold>Materials and methods:</bold> Sprague Dawley rats (<italic>n</italic>&#x02009;=&#x02009;6) were treated (p.o.) with 10% DMSO (Groups 1 and 2), 50&#x02009;mg/kg <italic>N</italic>-acetylcysteine (Group 3) or, 50, 250, or 500&#x02009;mg/kg MMCL (Groups 4&#x02013;6) for 7 consecutive days followed by pretreatment (i.p.) with vehicle (Group 1) or 50% CCl<sub>4</sub> in olive oil (v/v) (Groups 2&#x02013;6) on day 7th. Plasma liver enzymes and hepatic antioxidant enzymes and pro-inflammatory cytokines concentrations were measured while liver histopathology was examined.</p><p><bold>Results:</bold> MMCL, at 500&#x02009;mg/kg, significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) ameliorated CCl<sub>4</sub>-induced hepatotoxicity by decreasing the plasma level of alanine transaminase (429.1 versus 168.7&#x02009;U/L) and aspartate transaminase (513.8 versus 438.1&#x02009;U/L) as well as the tissue level of nitric oxide (62.7 versus 24.1&#x02009;nmol/g tissue). At 50, 250, or 500&#x02009;mg/kg, MMCL significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) reduced the tumour necrosis factor &#x003b1; (87.8 versus 32.7&#x02009;pg/mg tissue), interleukin-1&#x003b2; (1474.4 versus 618.3&#x02009;pg/mg tissue), and interleukin-6 (136.7 versus 30.8&#x02009;pg/mg tissue) while increased the liver catalase (92.1 versus 114.4&#x02009;U/g tissue) and superoxide dismutase (3.4 versus 5.5&#x02009;U/g tissue). Additionally, qualitative phytochemicals analysis showed that MMCL contained gallic acid, ferulic acid, quercetin, and genistein.</p><p><bold>Discussion and conclusions:</bold> MMCL ability to attenuate CCl<sub>4</sub>-induced hepatotoxicity could be helpful in the development of hepatoprotective agents with fewer side effects.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>Muntingiaceae</kwd><kwd>hepatoprotective activity</kwd><kwd>antioxidant activity</kwd><kwd>oxidative stress markers</kwd><kwd>pro-inflammatory mediators</kwd><kwd>phytoconstituents</kwd><kwd>UHPLC-ESI</kwd><kwd>GCMS</kwd></kwd-group><funding-group><award-group><funding-source><named-content content-type="funder-name">Research Acculturation Collaborative Effort</named-content></funding-source><award-id>R/RACE/A07.00/</award-id><award-id>0A/002/</award-id><award-id>/</award-id><award-id>34</award-id></award-group><award-group><funding-source><named-content content-type="funder-name">Universiti Putra Malaysia</named-content><named-content content-type="funderidentifier">10.13039/501100004530</named-content></funding-source></award-group><funding-statement>This research was supported by the Research Acculturation Collaborative Effort grant (RACE; Reference no: R/RACE/A07.00/00290A/002/2015/000234), which was awarded by the Universiti Putra Malaysia (UPM), Malaysia.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="8"/><page-count count="10"/><word-count count="7726"/></counts></article-meta></front><body><sec id="s0001"><title>Introduction</title><p>The liver plays a vital role in the metabolism and detoxification of various xenobiotics that could potentially harm the body. However, over-exposure to toxic chemicals that can cause oxidative stress and lipid peroxidation may result in liver damage. Among these chemicals is carbon tetrachloride (CCl<sub>4</sub>), a highly toxic compound causing liver damage through its conversion to free radicals by hepatic microsomal cytochrome P450 (CYP<sub>450</sub>) (Giannini et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2005</xref>; Manibusan et&#x000a0;al. <xref rid="CIT0018" ref-type="bibr">2007</xref>; Ohata et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2008</xref>). The generation of CCl<sub>3</sub> radical also inhibits lipoprotein secretion causing steatosis and CCI<sub>3</sub><sup>&#x02212;OO</sup> initiates lipid peroxidation in the liver (Boll et&#x000a0;al. <xref rid="CIT0005" ref-type="bibr">2001</xref>).</p><p>Currently, modern medicine still has little to offer for the prevention and attenuation of liver diseases and damages (Tukappa et&#x000a0;al. <xref rid="CIT0026" ref-type="bibr">2015</xref>). Thus, patients often resort to herbal products as an alternative source of treatment for their ailments. There are several hepatoprotective herbal-based compounds that purportedly possess oxidative stress detoxification properties with minimum or no side effects (Bezenjani et&#x000a0;al. <xref rid="CIT0004" ref-type="bibr">2012</xref>). One of the plants reported to possess high anti-inflammatory and antioxidant activities and as a potential source of hepatoprotective compounds is <italic>Muntingia calabura</italic> L. (Muntingiaceae) (Mahmood et&#x000a0;al. <xref rid="CIT0016" ref-type="bibr">2014a</xref>). Known to the Malays as <italic>&#x02018;kerukup siam&#x02019;</italic> or <italic>&#x02018;ceri kampung&#x02019;</italic>, <italic>M. calabura</italic> has no medicinal value in Malay folklore medicine, although it has been used in traditional medicine in several Southeast Asian and tropical American countries. Among traditional uses of parts of the tree are for the treatment of gastric ulcer, headache, cold, stomachache, measles, and pimples (Mahmood et&#x000a0;al. <xref rid="CIT0016" ref-type="bibr">2014a</xref>).</p><p>In accordance with these claims, scientific studies have revealed the vast pharmacological potential of different parts of <italic>M. calabura</italic>. Based on the literature review on <italic>M. calabura</italic> for pharmacological reports between 1991 and 2014, it has been reported to demonstrate cytotoxic, antiproliferative, insecticidal, hypotensive, antinociceptive, cardioprotective, antipyretic, antiplatelet aggregation, antioxidant, anti-inflammatory, antidiabetic, antiulcer, and antibacterial activities with approximately 87 flavonoid-based compounds identified (Mahmood et&#x000a0;al. <xref rid="CIT0016" ref-type="bibr">2014a</xref>).</p><p>We showed in an earlier study that methanol extract of <italic>M. calabura</italic> leaves (MMCL) (50&#x02013;500&#x02009;mg/kg) attenuates paracetamol (PCM)-induced liver injury (Mahmood et&#x000a0;al. <xref rid="CIT0015" ref-type="bibr">2014b</xref>). MMCL contains significant amounts of flavonoid, saponins, tannins, and some phenolic compounds, which are known to exert anti-inflammatory and antioxidant activities. It is through these components that MMCL ameliorated PCM-induced liver injury.</p><p>At this juncture, it is not known how the MMCL modulates liver metabolism in carbon tetrachloride (CCl<sub>4</sub>)-induced hepatotoxicity. Thus, in this study, we determined the effect of MMCL on CCl<sub>4</sub>-induced hepatotoxicity by estimating antioxidant activities, and release of oxidative stress markers and pro-inflammatory cytokines in the rat model.</p></sec><sec id="s0002"><title>Materials and methods</title><sec id="s0003"><title>Chemicals</title><p>Methanol, petroleum ether, and ethyl acetate, the solvents used for plant extraction and for phytochemical analyses including formic acid, and LCMS grade acetonitrile were purchased from MERCK (Selangor, Malaysia). The kits used for the determination of catalase and superoxide dismutase were purchased from Cayman Chemicals (Ann Arbor, MI). HPLC grade water was prepared from distilled water using a Milli-Q-system (Millipore, Waltham, MA). Gallic acid, kaempferol, kaempferol-3-<italic>O</italic>-glucoside, and quercetin were purchased from Sigma (St. Louis, MO), and isoferulic acid from Extrasynthese (Genay, France). All of other solvents and chemicals used in this study were of analytical grade. Stock and working standards for the phytochemical analyses were prepared by dissolving the analytes in 100% methanol and stored at 4&#x02009;&#x000b0;C until use.</p></sec><sec id="s0004"><title>Collection of plant material and preparation of plant extract</title><p>The collection of plant material and the preparation of plant extract have been described in detail elsewhere (Mahmood et&#x000a0;al. <xref rid="CIT0015" ref-type="bibr">2014b</xref>). Briefly, the leaves were collected from its natural habitat in Serdang, Selangor, Malaysia, authenticated by a certified botanist (Dr Shamsul Khamis of the Institute of Bioscience (IBS), UPM) based on the previous sample (voucher specimen &#x02013; SK 2466/14) and deposited in the Herbarium of Institute of Bioscience, Universiti Putra Malaysia (UPM).</p><p>The leaves were air-dried for 7&#x02009;days at room temperature (27&#x02009;&#x000b1;&#x02009;2&#x02009;&#x000b0;C) taking special care to avoid the formation of moulds on the leaves. The air-dried leaves (500&#x02009;g) were ground into a coarse powder and then immersed in 10&#x02009;L methanol [a ratio of 1:20 (w/v)] for 72&#x02009;h. The supernatant was filtered using cloth filter, cotton wool, and, finally, Whatman No. 1 filter paper. The remaining residue was subjected to the same extraction process twice. The supernatants were pooled and evaporated under reduced pressure at 40&#x02009;&#x000b0;C to obtain dried crude extract (% yield = 17.9%), which was kept at 4&#x02009;&#x000b0;C until use.</p></sec><sec id="s0005"><title>Animals</title><p>The study protocol was approved by the International Animal Care and Use Committee (IACUC), Faculty of Medicine and Health Sciences (FMHS), UPM (Ethical approval no: UPM/IACUC/AUP- R004/2014). Male Sprague&#x02013;Dawley rats aged 8&#x02013;10&#x02009;weeks and weighing 180&#x02013;200&#x02009;g were acquired from the Chenur Supplier, Selangor, Malaysia. The rats were housed in the Animal Holding Unit, FMHS, UPM, at room temperature (27&#x02009;&#x000b1;&#x02009;2&#x02009;&#x000b0;C) under 70&#x02013;80% humidity and 12&#x02009;h light/dark cycle. Food and water were provided <italic>ad libitum</italic>. The handling of rats was according to the guidelines for the care of laboratory animals and the ethical guidelines for investigation of experimental pain in conscious animals, FMHS, UPM. Data processing and making exclusions and decisions were done by experimenters blinded to the study. All sections of this report adhered to the ARRIVE Guidelines for reporting animal research. A completed ARRIVE guidelines checklist is included in Checklist S1.</p></sec><sec id="s0006"><title>Hepatoprotective assay</title><sec id="s0007"><title>Carbon tetrachloride-induced hepatotoxicity test</title><p>Each group was treated accordingly with either 10% DMSO (v/v) in distilled water (vehicle 1; Negative control), 50&#x02009;mg/kg <italic>N</italic>-acetylcysteine (NAC) or, 50, 250, or 500&#x02009;mg/kg MMCL once daily for 7 consecutive days (<xref rid="t0001" ref-type="table">Table 1</xref>). Oral administration was chosen to mimic the traditional way of consuming the plant extract while the dose range used was based on the data from the previous acute toxicity study (Balan et&#x000a0;al. <xref rid="CIT0002" ref-type="bibr">2014</xref>). The inducer, 1&#x02009;mL/kg body weight 50% CCl<sub>4</sub> (v/v) in olive oil, was administered orally on day 7 to all group of animals except Group 1, which received 50% olive oil (v/v) in water (vehicle 2) (used to dissolve CCl<sub>4</sub>) (Kamisan et&#x000a0;al. <xref rid="CIT0008" ref-type="bibr">2014</xref>). The rats were weighed at approximately 48&#x02009;h after the administration of CCl<sub>4</sub> and then anesthetized under diethyl ether. Approximately 3&#x02009;mL of blood were collected via cardiac puncture into lithium heparinized tubes for biochemical analysis. The blood samples were centrifuged at 1000&#x02009;&#x000d7;&#x02009;<italic>g</italic> for 10&#x02009;min using a refrigerated centrifuge to obtain plasma, which were transferred to clean polypropylene tubes and stored at &#x02212;80&#x02009;&#x000b0;C until use. The rats were then sacrificed by cervical dislocation the livers collected, weighed, and washed in ice-cold saline. A section from the median lobe of the liver was fixed in 10% formalin for microscopic analysis and the remainder immediately frozen on dry ice and stored at &#x02212;80&#x02009;&#x000b0;C until use. </p><table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Brief explanation on the experimental design for MMCL-induced hepatoprotective study.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th colspan="2" align="left">Group</th><th align="center">Administration of test solution (p.o.)</th><th align="center">Dose (mg/kg)</th><th align="center">Administration of inducer of day 7</th></tr></thead><tbody valign="top"><tr><td align="left">1</td><td align="left">Normal</td><td align="center">10% DMSO (vehicle 1)</td><td align="center">&#x02013;</td><td align="center"><bold>50%</bold> olive oil (vehicle 2)</td></tr><tr><td align="left">2</td><td align="left">Negative</td><td align="center">10% DMSO (vehicle 1)</td><td align="center">&#x02013;</td><td align="center">CCl<sub>4</sub></td></tr><tr><td align="left">3</td><td align="left">Positive</td><td align="center">NAC</td><td align="center">50</td><td align="center">CCl<sub>4</sub></td></tr><tr><td align="left">4</td><td rowspan="3">Treatment</td><td rowspan="3" align="center">MMCL</td><td align="center">50</td><td align="center">CCl<sub>4</sub></td></tr><tr><td align="left">5</td><td align="center">250</td><td align="center">CCl<sub>4</sub></td></tr><tr><td align="left">6</td><td align="center">500</td><td align="center">CCl<sub>4</sub></td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p>NAC: <italic>N</italic>-acetylcysteine; Vehicle 1 &#x02013; used to dissolve NAC and MMCL; Vehicle 2 &#x02013; used to dissolve CCl<sub>4</sub>.</p></fn><fn id="TF2"><p>The rats (<italic>n</italic>&#x02009;=&#x02009;6) were pretreated with the respective test solutions for 7&#x02009;days followed by CCl<sub>4</sub>-induced hepatotoxicity assay on day 7.</p></fn></table-wrap-foot></table-wrap></sec></sec></sec><sec id="s0008"><title>Plasma liver enzymes</title><p>The plasma alanine aminotransaminase (ALT), aspartate aminotransaminase (AST), and alkaline phosphatase (ALP) concentrations were determined spectrophotometrically by means of the Automatic Chemical Analyzer (Hitachi 902, Tokyo, Japan) using commercial kits (BioMed Diagnostics, White City, OR).</p></sec><sec id="s0009"><title>Liver homogenate antioxidant enzyme, pro-inflammatory cytokines, and nitric oxide concentrations</title><sec id="s0010"><title>Preparation of liver homogenates for antioxidant study</title><p>Approximately 100&#x02009;mg of liver tissue were homogenized in 1&#x02009;mL ice-cold PBS buffer using a steel homogenizer. The homogenate was further centrifuged at 4000&#x02009;rpm and 4&#x02009;&#x000b0;C (Thermo Scientific centrifuge (Thermo Fisher Scientific Co., Waltham, MA), Legend Micro 17&#x02009;R) for 25&#x02009;min to obtain supernatant, which was used for the determination of superoxide dismutase (SOD) and catalase (CAT) (Zakaria et&#x000a0;al. <xref rid="CIT0031" ref-type="bibr">2015</xref>), nitric oxide (NO) (Malyshev and Shnyra <xref rid="CIT0017" ref-type="bibr">2003</xref>) and interleukin-1&#x003b2; (IL-1&#x003b2;), interleukin-6 (IL-6), and tumour necrosis factor alpha (TNF-&#x003b1;) concentrations (Liu et&#x000a0;al. <xref rid="CIT0014" ref-type="bibr">2016</xref>) concentrations.</p></sec><sec id="s0011"><title>Superoxide dismutase</title><p>The SOD activity of the liver tissue samples was measured using the standard kit (Cayman Chemical, Ann Arbor, MI) according to the manufacturer&#x02019;s protocol. Briefly, 10&#x02009;&#x003bc;L of 0, 0.005, 0.01, 0.02, 0.03, 0.04, or 0.05&#x02009;U/mL SOD standard or samples was added to each well, followed by 200&#x02009;&#x003bc;L diluted radical detector. The reactions were initiated with the addition of 20&#x02009;&#x003bc;L diluted xanthine oxidase. The plate was then gently shaken, covered, and incubated on a shaker at room temperature for 30&#x02009;min. Absorbance was read at 440&#x02013;460&#x02009;nm using the ELISA microplate reader (Asys UVM 340, Wolf Laboratories Limited, York, UK). SOD activity Unit, defined as the quantity of enzyme needed to cause 50% dismutation of the superoxide radical and the SOD activity, was expressed as per gram tissue (Zakaria et&#x000a0;al. <xref rid="CIT0031" ref-type="bibr">2015</xref>).</p></sec><sec id="s0012"><title>Catalase</title><p>The liver tissue CAT activity was measured using the standard kit (Cayman Chemical, Ann Arbor, MI) according to the manufacturer&#x02019;s protocol. Briefly, 20&#x02009;&#x003bc;L of formaldehyde standard, CAT formaldehyde standard (positive control) at 0, 5, 15, 30, 45, 60, or 75&#x02009;&#x003bc;M, or samples were added to the respective well of a 96-well plate followed by 30&#x02009;&#x003bc;L methanol and 100&#x02009;&#x003bc;L diluted assay buffer. To each of these wells, approximately 20&#x02009;&#x003bc;L of diluted hydrogen peroxide were added to initiate the reaction. The plate was covered and incubated on a shaker at room temperature for 20&#x02009;min. Approximately 30&#x02009;&#x003bc;L diluted potassium hydroxide were added to each well, to stop the reaction, followed by 30&#x02009;&#x003bc;L of CAT purpald (chromogen). The plate was incubated on a shaker at room temperature for 10&#x02009;min. Finally, approximately 10&#x02009;&#x003bc;L of CAT potassium periodate were added to each well and the plate was incubated on a shaker at room temperature for another 5&#x02009;min. The absorbance was determined at 540&#x02009;nm using the ELISA microplate reader (Asys UVM 340, Wolf Laboratories Limited, York, UK). Catalase activity was the quantity of enzyme that caused formation of 1.0&#x02009;nmol formaldehyde per min at 25&#x02009;&#x000b0;C and expressed as unit per gram tissue (Zakaria et&#x000a0;al. <xref rid="CIT0031" ref-type="bibr">2015</xref>).</p></sec><sec id="s0013"><title>Nitric oxide</title><p>Nitric oxide (NO) concentration was spectrophotometrically estimated in the liver homogenate using kits (eBioscience, San Diego, CA). The homogenate was incubated with absolute ethanol for 48&#x02009;h to precipitate protein. Following centrifugation at 10,000&#x02009;rpm for 5&#x02009;min, the supernatants were incubated with 200&#x02009;mL vanadium trichloride (8&#x02009;mg/mL in 1&#x02009;N HCl), and then Griess reagent was added. The mixture was then incubated at 37&#x02009;&#x000b0;C for 30&#x02009;min, cooled, and the absorbance was determined at 540&#x02009;nm. The results were expressed as nmol/g of wet tissue.</p></sec><sec id="s0014"><title>Interleukin-1&#x000df;, interleukin-6, and tumour necrotic factor</title><p>The concentrations of IL-1&#x003b2;, IL-6, and TNF-&#x003b1; in the supernatant from homogenized liver tissue were measured using ELISA kits (eBioscience, San Diego, CA) according to the manufacturer&#x02019;s instructions (Liu et&#x000a0;al. <xref rid="CIT0014" ref-type="bibr">2016</xref>; Zhang et&#x000a0;al. <xref rid="CIT0035" ref-type="bibr">2017</xref>). Briefly, a capture antibody was added to each well of a 96-well plate and incubated overnight. Then, biotinylated antibody was added and incubated with supernatants or standard antigens. Finally, streptavidin was added to end the reaction, and the absorbance recorded at 450&#x02009;nm. The results are expressed in picograms per milligram of protein (pg/mg) for cytokine concentrations.</p></sec></sec><sec id="s0015"><title>Histopathological analyses</title><p>Liver tissue sample from each rat was fixed in 10% formalin, embedded in paraffin, and then sectioned to 3&#x02013;5&#x02009;&#x000b5;m thick specimen. Each specimen was then stained with haematoxylin and eosin prior to the microscopic examination. The severity of liver tissue lesions was classified according to method described by Heikal et&#x000a0;al. (<xref rid="CIT0007" ref-type="bibr">2013</xref>) with slight modifications. Histopathological changes were scored as follows: (&#x02212;) absent; (+) mild; (++) moderate, and (+++) severe.</p></sec><sec id="s0016"><title>Phytochemicals analyses of MMCL</title><sec id="s0017"><title>UHPLC&#x02013;ESI and GCMS analyses of MMCL</title><p>The UHPLC-ESI and GCMS analyses of MMCL were performed according to their procedure described elsewhere (Abdul Rahim et&#x000a0;al. <xref rid="CIT0001" ref-type="bibr">2016</xref>). Briefly, the UHPLC-ESI analysis was performed using the Dionex 3000 UHPLC system (Thermo Fisher Scientific, Waltham, MA) whereas the chromatographic separation was performed using the BEH C18 UHPLC column (100&#x02009;mm &#x000d7; 2.5&#x02009;&#x000b5;m &#x000d7; 1.7&#x02009;&#x000b5;m) maintained at 40&#x02009;&#x000b0;C (Waters, Milford, MA). The flow-rate used was 0.3&#x02009;mL/min and the injection volume was 10&#x02009;&#x000b5;L of mobile phases comprising 0.1% formic acid in water (solution A) and 0.1% formic acid in acetonitrile (solution B). The gradient was initiated with 10% mobile phase B that reached 20% at 5&#x02009;min. By 17&#x02009;min, the gradient reached 60% mobile phase B before reaching the isocratic elution of 90% B after another 3&#x02009;min. The gradient was held for 2&#x02009;min for re-equilibration. The UHPLC system was coupled to a linear ion-trap-Orbitrap mass spectrometer Q Exactive from Thermo Fisher Scientific (Waltham, MA) supplied with an electrospray ionization (ESI) source. Instrument control and data acquisition were performed with Chameleon 6.8 software and Xcalibur 2.2 software (Thermo Fisher Scientific, Waltham, MA).</p><p>GC-MS analysis of MMCL was achieved using the Agilent 7890&#x02009;A (Agilent Technologies, Santa Clara, CA) coupled with MSD quadrupole detector 5975&#x02009;C (Agilent Technologies, Santa Clara, CA) (Abdul Rahim et&#x000a0;al. <xref rid="CIT0001" ref-type="bibr">2016</xref>). The HP-5MS silica capillary column (30&#x02009;m&#x02009;&#x000d7;&#x02009;0.25&#x02009;mm &#x000d7; 0.25&#x02009;mm; Hewlett Packard) was used to separate the analytes in MMCL. An injection volume of 1&#x02009;&#x003bc;L was employed (a split ratio of 1:10) with the carrier gas (helium gas; 99.999%) applied at a constant flow-rate of 1.0&#x02009;mL/min. Total GC running time was 35.50&#x02009;min. Mass spectra were taken at 70&#x02009;eV at a scan interval of 0.5&#x02009;s and fragments from 45 to 450&#x02009;Da. The relative % of each component was calculated by comparing its average peak area to the total area. The software, Turbomass, used to handle mass spectra and chromatograms. Mass spectrum GC-MS interpretation was conducted using the database of National Institute Standard and Technology (NIST). The spectrum of the unknown components was compared with those of known components stored in the NIST library.</p></sec></sec><sec id="s0018"><title>Statistical analysis</title><p>All the data are presented as mean&#x02009;&#x000b1;&#x02009;SEM. Statistical analysis was performed using GraphPad Prism version 5 (GraphPad Software, La Jolla, CA). Data obtained were analyzed using the one-way analysis of variance (ANOVA) and the differences between groups and the control group was determined using Dunnett&#x02019;s <italic>post hoc</italic> test with <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 as the limit of significance.</p></sec><sec id="s0019"><title>Results</title><sec id="s0020"><title>Hepatoprotective activity of MMCL</title><p><xref rid="t0002" ref-type="table">Table 2</xref> shows the organ weight and body weight of rats with CCl<sub>4</sub>-induced liver damage pretreated with MMCL. The liver to body weight (LW/BW) was significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) higher in CCl<sub>4</sub>-treated and normal control group rats. Interestingly, pretreatment with MMCL significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) reduced LW/BW ratio in comparison with the CCl<sub>4</sub>-treated group in a dose-dependent manner.</p><table-wrap id="t0002" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Effect of MEMC on body and liver weight in CCl<sub>4</sub>-treated rats.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Treatment</th><th align="center">Dose (mg/kg)</th><th align="center">Body Weight (BW) (g)</th><th align="center">Liver Weight (LW) (g)</th><th align="center">LW/BW (%)</th></tr></thead><tbody valign="top"><tr><td align="left">Normal</td><td align="center">&#x02013;</td><td align="char" char=".">204.1&#x02009;&#x000b1;&#x02009;3.7</td><td align="char" char="&#x000b1;">5. 6&#x02009;&#x000b1;&#x02009;0.2</td><td align="char" char=".">2.7&#x02009;&#x000b1;&#x02009;0.1</td></tr><tr><td align="left">10% DMSO&#x02009;+&#x02009;CCl<sub>4</sub></td><td align="center">&#x02013;</td><td align="char" char=".">208.9&#x02009;&#x000b1;&#x02009;8.0</td><td align="char" char="&#x000b1;">10.3&#x02009;&#x000b1;&#x02009;0.3<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></td><td align="char" char=".">5.0&#x02009;&#x000b1;&#x02009;0.2<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></td></tr><tr><td align="left">NAC&#x02009;+&#x02009;CCl<sub>4</sub></td><td align="char" char=".">50</td><td align="char" char=".">190.2&#x02009;&#x000b1;&#x02009;2.2</td><td align="char" char="&#x000b1;">7.6&#x02009;&#x000b1;&#x02009;0.4<sup>ab</sup></td><td align="char" char=".">4.0&#x02009;&#x000b1;&#x02009;0.2<sup>ab</sup></td></tr><tr><td align="left">MEMC&#x02009;+&#x02009;CCl<sub>4</sub></td><td align="char" char=".">50</td><td align="char" char=".">187.2&#x02009;&#x000b1;&#x02009;3.1</td><td align="char" char="&#x000b1;">7.9&#x02009;&#x000b1;&#x02009;0.3<sup>ab</sup></td><td align="char" char=".">4.5&#x02009;&#x000b1;&#x02009;0.2<xref ref-type="table-fn" rid="TF4"><sup>a</sup></xref></td></tr><tr><td align="left">&#x000a0;</td><td align="char" char=".">250</td><td align="char" char=".">205.8&#x02009;&#x000b1;&#x02009;3.1</td><td align="char" char="&#x000b1;">6.6&#x02009;&#x000b1;&#x02009;1.0<sup>ab</sup></td><td align="char" char=".">3.2&#x02009;&#x000b1;&#x02009;0.5<xref ref-type="table-fn" rid="TF5"><sup>b</sup></xref></td></tr><tr><td align="left">&#x000a0;</td><td align="char" char=".">500</td><td align="char" char=".">190.9&#x02009;&#x000b1;&#x02009;3.3</td><td align="char" char="&#x000b1;">6.6&#x02009;&#x000b1;&#x02009;0.1<sup>ab</sup></td><td align="char" char=".">3.5&#x02009;&#x000b1;&#x02009;0.1<xref ref-type="table-fn" rid="TF5"><sup>b</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="TF3"><p>Values are expressed as means&#x02009;&#x000b1;&#x02009;S.E.M. of six replicates.</p></fn><fn id="TF4"><label>a</label><p>Significant different as compared with normal control, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF5"><label>b</label><p>Significant different as compared with negative control (10% DMSO&#x02009;+&#x02009;CCl<sub>4</sub>), <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s0021"><title>Blood liver enzymes</title><p><xref rid="t0003" ref-type="table">Table 3</xref> shows the concentrations of plasma liver enzymes in rats with CCl<sub>4</sub>-induced liver damage pretreated with MMCL. The negative group showed significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) higher plasma ALT, AST, and ALP concentrations than the normal group. The plasma ALT and AST, but not ALP concentrations were significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) lower only in rats pretreatment with 500&#x02009;mg/kg body weight MMCL. On the other hand, NAC significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) reduced all plasma enzyme levels.</p><table-wrap id="t0003" orientation="portrait" position="float"><label>Table 3.</label><caption><p>Blood level of liver enzymes in hepatotoxic rats pretreated with MMCL.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Treatment</th><th align="center">Dose (mg/kg)</th><th align="center">ALT (U/L)</th><th align="center">AST (U/L)</th><th align="center">ALP (U/L)</th></tr></thead><tbody valign="top"><tr><td align="left">Normal</td><td align="center">&#x02013;</td><td align="char" char=".">15.8&#x02009;&#x000b1;&#x02009;3.5</td><td align="char" char=".">95.1&#x02009;&#x000b1;&#x02009;7.3</td><td align="char" char=".">102.7&#x02009;&#x000b1;&#x02009;5.5</td></tr><tr><td align="left">10% DMSO&#x02009;+&#x02009;CCl<sub>4</sub></td><td align="center">&#x02013;</td><td align="char" char=".">429.1&#x02009;&#x000b1;&#x02009;81.5<xref ref-type="table-fn" rid="TF7"><sup>a</sup></xref></td><td align="char" char=".">513.8&#x02009;&#x000b1;&#x02009;12.0<xref ref-type="table-fn" rid="TF7"><sup>a</sup></xref></td><td align="char" char=".">562.3&#x02009;&#x000b1;&#x02009;36.8<xref ref-type="table-fn" rid="TF7"><sup>a</sup></xref></td></tr><tr><td align="left">NAC&#x02009;+&#x02009;CCl<sub>4</sub></td><td align="center">50</td><td align="char" char=".">191.7&#x02009;&#x000b1;&#x02009;72.7<sup>bc</sup></td><td align="char" char=".">147.9&#x02009;&#x000b1;&#x02009;27.2<sup>bc</sup></td><td align="char" char=".">216.7&#x02009;&#x000b1;&#x02009;25.0<sup>bc</sup></td></tr><tr><td align="left">&#x000a0;</td><td align="center">50</td><td align="char" char=".">634.1&#x02009;&#x000b1;&#x02009;24.1<sup>cd</sup></td><td align="char" char=".">990.6&#x02009;&#x000b1;&#x02009;39.7<sup>cd</sup></td><td align="char" char=".">566.7&#x02009;&#x000b1;&#x02009;19.4<xref ref-type="table-fn" rid="TF9"><sup>c</sup></xref></td></tr><tr><td align="left">MMCL&#x02009;+&#x02009;CCl<sub>4</sub></td><td align="center">250</td><td align="char" char=".">333.0&#x02009;&#x000b1;&#x02009;15.3<xref ref-type="table-fn" rid="TF9"><sup>c</sup></xref></td><td align="char" char=".">723.1&#x02009;&#x000b1;&#x02009;28.9<sup>cd</sup></td><td align="char" char=".">498.7&#x02009;&#x000b1;&#x02009;68.4<xref ref-type="table-fn" rid="TF9"><sup>c</sup></xref></td></tr><tr><td align="left">&#x000a0;</td><td align="center">500</td><td align="char" char=".">168.7&#x02009;&#x000b1;&#x02009;12.0<xref ref-type="table-fn" rid="TF8"><sup>b</sup></xref><sup>c</sup></td><td align="char" char=".">438.1&#x02009;&#x000b1;&#x02009;16.3<sup>bc</sup></td><td align="char" char=".">454.7&#x02009;&#x000b1;&#x02009;21.9<sup>bc</sup></td></tr></tbody></table><table-wrap-foot><fn id="TF6"><p>Values are expressed as means&#x02009;&#x000b1;&#x02009;S.E.M. of six replicates.</p></fn><fn id="TF7"><label>a</label><p>Significantly different when compared with the normal group following treatment with vehicle, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF8"><label>b</label><p>Significantly different when compared with negative control, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF9"><label>c</label><p>Significantly higher when compared with the normal group following treatment with test solutions, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF10"><label>d</label><p>Significantly higher when compared with negative control, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF11"><p>ALT: alanine amino transaminase; AST: aspartate amino transaminase; ALP: alkaline phosphatase.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s0022"><title>Superoxide dismutase and catalase</title><p><xref rid="t0004" ref-type="table">Table 4</xref> shows the SOD and CAT activities in liver tissue of rats with CCl<sub>4</sub>-induced liver damage pretreated with MMCL. From the results, the hepatotoxic group (negative) showed significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) lower SOD and CAT activities that the normal group. NAC and MMCL, at various doses, significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) reversed the effect of CCl<sub>4</sub> on liver&#x02019;s antioxidant enzymes by increasing the activities towards normal value.</p><table-wrap id="t0004" orientation="portrait" position="float"><label>Table 4.</label><caption><p>Effect of MMCL on antioxidant enzymes activity in liver tissue of CCl<sub>4</sub>-treated rats.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Treatment</th><th align="center">Dose (mg/kg)</th><th align="center">SOD (U/g tissue)</th><th align="center">CAT (U/g tissue)</th></tr></thead><tbody valign="top"><tr><td align="left">Normal</td><td align="center">&#x02013;</td><td align="char" char="&#x000b1;">9.4&#x02009;&#x000b1;&#x02009;0.8</td><td align="char" char=".">122.3&#x02009;&#x000b1;&#x02009;0.7</td></tr><tr><td align="left">10% DMSO&#x02009;+&#x02009;CCl<sub>4</sub></td><td align="center">&#x000a0;</td><td align="char" char="&#x000b1;">3.4&#x02009;&#x000b1;&#x02009;0.2<xref ref-type="table-fn" rid="TF13"><sup>a</sup></xref></td><td align="char" char=".">92.1&#x02009;&#x000b1;&#x02009;1.0<xref ref-type="table-fn" rid="TF13"><sup>a</sup></xref></td></tr><tr><td align="left">NAC&#x02009;+&#x02009;CCl<sub>4</sub></td><td align="center">50</td><td align="char" char="&#x000b1;">8.7&#x02009;&#x000b1;&#x02009;1.7<xref ref-type="table-fn" rid="TF14"><sup>b</sup></xref></td><td align="char" char=".">121.7&#x02009;&#x000b1;&#x02009;1.5<xref ref-type="table-fn" rid="TF14"><sup>b</sup></xref></td></tr><tr><td rowspan="3">MMCL&#x02009;+&#x02009;CCl<sub>4</sub></td><td align="center">50</td><td align="char" char="&#x000b1;">6.1&#x02009;&#x000b1;&#x02009;1.3<xref ref-type="table-fn" rid="TF14"><sup>b</sup></xref></td><td align="char" char=".">116.9&#x02009;&#x000b1;&#x02009;0.7<xref ref-type="table-fn" rid="TF14"><sup>b</sup></xref></td></tr><tr><td align="center">250</td><td align="char" char="&#x000b1;">6.0&#x02009;&#x000b1;&#x02009;0.4<xref ref-type="table-fn" rid="TF14"><sup>b</sup></xref></td><td align="char" char=".">115.4&#x02009;&#x000b1;&#x02009;2.0<xref ref-type="table-fn" rid="TF14"><sup>b</sup></xref></td></tr><tr><td align="center">500</td><td align="char" char="&#x000b1;">5.5&#x02009;&#x000b1;&#x02009;0.8<xref ref-type="table-fn" rid="TF14"><sup>b</sup></xref></td><td align="char" char=".">114.4&#x02009;&#x000b1;&#x02009;1.8<xref ref-type="table-fn" rid="TF14"><sup>b</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="TF12"><p>Values are expressed as means&#x02009;&#x000b1;&#x02009;S.E.M. of six replicates.</p></fn><fn id="TF13"><label>a</label><p>Significant different as compared with normal control, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF14"><label>b</label><p>Significant different as compared with negative control (10% DMSO&#x02009;+&#x02009;CCl<sub>4</sub>), <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF15"><p>SOD: superoxide dismutase; CAT: catalase.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s0023"><title>Nitric oxide, tumour necrosis factor alpha, interleukin-1&#x003b2;, and interleukin-6</title><p><xref rid="t0005" ref-type="table">Table 5</xref> shows the NO, TNF-&#x003b1;, IL-1&#x003b2;, and IL-6 concentrations in liver tissue of rats with CCl<sub>4</sub>-induced liver damage pretreated with MMCL. The NO concentration in the homogenates of CCl<sub>4</sub>-induced liver damage was significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) lower than in the normal liver. Interestingly, pretreatment with 250 and 500&#x02009;mg/kg body weight MMCL significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) reversed the effect of CCl<sub>4</sub> on NO level, causing the NO concentration to return to normal.</p><table-wrap id="t0005" orientation="portrait" position="float"><label>Table 5.</label><caption><p>Effect of MMCL on pro-inflammatory cytokines level in liver tissue of CCl<sub>4</sub>-treated rats.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Treatment</th><th align="center">Dose (mg/kg)</th><th align="center">NO (nmol/g tissue)</th><th align="center">TNF-&#x003b1; (pg/mg protein)</th><th align="center">IL-1&#x003b2; (pg/mg protein)</th><th align="center">IL-6 (pg/mg protein)</th></tr></thead><tbody valign="top"><tr><td align="left">Normal</td><td align="center">&#x02013;</td><td align="char" char="&#x000b1;">18. 6&#x02009;&#x000b1;&#x02009;2.6</td><td align="char" char=".">29.7&#x02009;&#x000b1;&#x02009;2.4</td><td align="char" char=".">184.7&#x02009;&#x000b1;&#x02009;11.8</td><td align="char" char=".">21.5&#x02009;&#x000b1;&#x02009;3.1</td></tr><tr><td align="left">10% DMSO&#x02009;+&#x02009;CCl<sub>4</sub></td><td align="center">&#x02013;</td><td align="char" char="&#x000b1;">62.7&#x02009;&#x000b1;&#x02009;11.8<xref ref-type="table-fn" rid="TF17"><sup>a</sup></xref></td><td align="char" char=".">87.8&#x02009;&#x000b1;&#x02009;3.7<xref ref-type="table-fn" rid="TF17"><sup>a</sup></xref></td><td align="char" char=".">1474.4&#x02009;&#x000b1;&#x02009;21.3<xref ref-type="table-fn" rid="TF17"><sup>a</sup></xref></td><td align="char" char=".">136.7&#x02009;&#x000b1;&#x02009;17.3<xref ref-type="table-fn" rid="TF17"><sup>a</sup></xref></td></tr><tr><td rowspan="3">MMCL&#x02009;+&#x02009;CCl<sub>4</sub></td><td align="center">50</td><td align="char" char="&#x000b1;">53.5&#x02009;&#x000b1;&#x02009;4.7</td><td align="char" char=".">63.7&#x02009;&#x000b1;&#x02009;4.1<xref ref-type="table-fn" rid="TF18"><sup>b</sup></xref></td><td align="char" char=".">1167.1&#x02009;&#x000b1;&#x02009;20.3<xref ref-type="table-fn" rid="TF18"><sup>b</sup></xref></td><td align="char" char=".">98.2&#x02009;&#x000b1;&#x02009;12.6<xref ref-type="table-fn" rid="TF18"><sup>b</sup></xref></td></tr><tr><td align="center">250</td><td align="char" char="&#x000b1;">33.4&#x02009;&#x000b1;&#x02009;5.1<xref ref-type="table-fn" rid="TF18"><sup>b</sup></xref></td><td align="char" char=".">41.6&#x02009;&#x000b1;&#x02009;2.0<xref ref-type="table-fn" rid="TF18"><sup>b</sup></xref></td><td align="char" char=".">839.6&#x02009;&#x000b1;&#x02009;14.9<xref ref-type="table-fn" rid="TF18"><sup>b</sup></xref></td><td align="char" char=".">50.3&#x02009;&#x000b1;&#x02009;8.7<xref ref-type="table-fn" rid="TF18"><sup>b</sup></xref></td></tr><tr><td align="center">500</td><td align="char" char="&#x000b1;">24.1&#x02009;&#x000b1;&#x02009;3.9<xref ref-type="table-fn" rid="TF18"><sup>b</sup></xref></td><td align="char" char=".">32.7&#x02009;&#x000b1;&#x02009;2.8<xref ref-type="table-fn" rid="TF18"><sup>b</sup></xref></td><td align="char" char=".">618.3&#x02009;&#x000b1;&#x02009;42.4<xref ref-type="table-fn" rid="TF18"><sup>b</sup></xref></td><td align="char" char=".">30.8&#x02009;&#x000b1;&#x02009;6.1<xref ref-type="table-fn" rid="TF18"><sup>b</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="TF16"><p>Values are expressed as means&#x02009;&#x000b1;&#x02009;S.E.M. of six replicates.</p></fn><fn id="TF17"><label>a</label><p>Significant different as compared with normal control, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF18"><label>b</label><p>Significant different as compared with negative control (10% DMSO&#x02009;+&#x02009;CCl<sub>4</sub>), <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF19"><p>NO: nitric oxide; TNF-&#x003b1;: tumour necrosis factor alpha; IL-1&#x003b2;: interleukin 1&#x003b2;; IL-6: interleukin 6.</p></fn></table-wrap-foot></table-wrap><p>The hepatotoxic effect of CCl<sub>4</sub> has led to significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) higher TNF-&#x003b1;, IL-1&#x003b2;, and IL-6 concentrations in liver tissues of treated than normal. However, pretreatment with 250 and 500&#x02009;mg/kg body weight MMCL caused significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) lower concentrations of these inflammatory in these liver tissues than those not treated.</p></sec><sec id="s0024"><title>Histopathology</title><p>The ability of MMCL to reverse the hepatotoxic effect of CCl<sub>4</sub> was shown by the histopathological changes in the liver (<xref ref-type="fig" rid="F0001">Figure 1</xref>). Liver tissues of non-treated CCl<sub>4</sub>-induced hepatotoxic rats showed massive necrosis, marked inflammation, and mild steatosis (<xref ref-type="fig" rid="F0001">Figure 1(B)</xref>). Pretreatment with 50&#x02009;mg/kg body weight of NAC prevented the development of these severe lesions, although the liver still showed centrilobular necrosis, steatosis, and haemorrhage (<xref ref-type="fig" rid="F0001">Figure 1(C)</xref>). The hepatoprotective effect of MMCL was only evident in rats treated with the highest dose of 500&#x02009;mg/kg body weight used in the study. These rats had almost normal liver architecture, except for the mild centrilobular necrosis and inflammation (<xref ref-type="fig" rid="F0001">Figure 1(F)</xref> and <xref rid="t0006" ref-type="table">Table 6</xref>).</p><fig id="F0001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Microscopic analysis of liver section of normal and CCl<sub>4</sub>-induced hepatotoxic rats following pretreatment with 10% DMSO, NAC or MMCL. (A) Liver section of normal control animal exhibits normal hepatic cells each with well-defined cytoplasm, prominent nucleus and nucleolus and well brought central vein; (B) liver section of CCl<sub>4</sub>-induced hepatotoxic rats pretreated with 10% DMSO shows total loss of hepatic architecture with massive centrilobular hepatic necrosis, massive fatty changes vacuolization (steatosis), Kupffer cell hyperplasia and apoptosis; (C) liver section of CCl<sub>4</sub>-induced hepatotoxic rats pretreated with 50&#x02009;mg/kg body weight of NAC demonstrates mild centrilobular hepatic necrosis, mark steatosis and mild haemorrhage; (D) liver section of CCl<sub>4</sub>-induced hepatotoxic rats pretreated with 50&#x02009;mg/kg MMCL exhibits total loss of hepatic architecture with massive centrilobular hepatic necrosis, massive steatosis, kupffer cell hyperplasia, massive inflammation, massive haemorrhage and apoptosis; (E) liver section of CCl<sub>4</sub>-induced hepatotoxic rats pretreated with 250&#x02009;mg/kg MMCL exhibits mark centrilobular hepatic necrosis, mild steatosis, marked inflammation, and mild haemorrhage; and (F) liver section of CCl<sub>4</sub>-induced hepatotoxic rats pretreated with 500&#x02009;mg/kg MMCL shows normal liver architecture with mild centrilobular hepatic necrosis, mild inflammation (100&#x000d7; magnification). CV: central vein; N: necrosis; I: inflammation; S: steatosis.</p></caption><graphic content-type="color" xlink:href="IPHB_A_1606836_F0001_C"/></fig><table-wrap id="t0006" orientation="portrait" position="float"><label>Table 6.</label><caption><p>Histopathological scoring of the tissue of CCl<sub>4</sub>-induced hepatic injury rats after pretreatment with MMCL.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Treatment</th><th align="center">Dose (mg/kg)</th><th align="center">Steatosis</th><th align="center">Necrosis</th><th align="center">Inflammation</th><th align="center">Haemorrhage</th></tr></thead><tbody valign="top"><tr><td align="left">Normal</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td></tr><tr><td>10% DMSO&#x02009;+&#x02009;CCl<sub>4</sub></td><td>&#x000a0;</td><td align="char" char=".">++</td><td align="char" char=".">+++</td><td align="char" char=".">+++</td><td align="char" char=".">+</td></tr><tr><td align="left">NAC&#x02009;+&#x02009;CCl<sub>4</sub></td><td align="char" char=".">50</td><td align="char" char=".">+</td><td align="char" char=".">+</td><td align="char" char=".">+</td><td align="char" char=".">+</td></tr><tr><td align="left">&#x000a0;</td><td align="char" char=".">50</td><td align="char" char=".">++</td><td align="char" char=".">+++</td><td align="char" char=".">+++</td><td align="char" char=".">+++</td></tr><tr><td align="left">MMCL&#x02009;+&#x02009;CCl<sub>4</sub></td><td align="char" char=".">250</td><td align="char" char=".">+</td><td align="char" char=".">++</td><td align="char" char=".">++</td><td align="char" char=".">++</td></tr><tr><td align="left">&#x000a0;</td><td align="char" char=".">500</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td><td align="char" char=".">&#x02212;</td></tr></tbody></table><table-wrap-foot><fn id="TF20"><p>Histopathological score: (&#x02212;) absent; (+) mild; (++) moderate, and (+++) severe.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s0025"><title>Phytochemicals analyses of MMCL</title><sec id="s0026"><title>UHPLC&#x02013;ESI analysis of MMCL &#x02013; identification of phenolic compounds in MMCL</title><p>The UHPLC-ESI analysis showed that MMCL contains 26 phenolic compounds (<xref ref-type="fig" rid="F0002">Figure 2</xref> and <xref rid="t0007" ref-type="table">Table 7</xref>).</p><fig id="F0002" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Total ion chromatography (TIC) of MMCL obtained using the UHPLC instrument in negative ion mode.</p></caption><graphic content-type="black-white" xlink:href="IPHB_A_1606836_F0002_B"/></fig><table-wrap id="t0007" orientation="portrait" position="float"><label>Table 7.</label><caption><p>Phenolic compounds identified in MMCL by UHPLC-MS.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Peak no.</th><th align="center"><italic>R</italic><sub>T</sub> (min)</th><th align="center">[M-H]-</th><th align="center">Error (ppm)</th><th align="center">Formula</th><th align="center">Identification</th></tr></thead><tbody valign="top"><tr><td>1.</td><td align="char" char=".">0.46</td><td align="char" char=".">169.01392</td><td align="char" char=".">5.090</td><td>C<sub>7</sub>H<sub>5</sub>O<sub>5</sub></td><td>Gallic acid</td></tr><tr><td>2.</td><td align="char" char=".">2.21</td><td align="char" char=".">163.03985</td><td align="char" char=".">5.394</td><td>C<sub>9</sub>H<sub>7</sub>O<sub>3</sub></td><td>Protocatechuic acid</td></tr><tr><td>3.</td><td align="char" char=".">3.16</td><td align="char" char=".">193.05023</td><td align="char" char=".">3.599</td><td>C<sub>10</sub>H<sub>9</sub>O<sub>4</sub></td><td>Ferulic acid</td></tr><tr><td>4.</td><td align="char" char=".">3.95</td><td align="char" char=".">477.06860</td><td align="char" char=".">4.681</td><td>C<sub>21</sub>H<sub>17</sub>O<sub>13</sub></td><td>Quercetin-3-<italic>O</italic>-glucuronide</td></tr><tr><td>5.</td><td align="char" char=".">4.58</td><td align="char" char=".">599.10559</td><td align="char" char=".">4.079</td><td>C<sub>28</sub>H<sub>23</sub>O<sub>15</sub></td><td>Quercitrin-2&#x02033;-O-gallate</td></tr><tr><td>6.</td><td align="char" char=".">4.93</td><td align="char" char=".">939.11462</td><td align="char" char=".">5.125</td><td>C<sub>41</sub>H<sub>31</sub>O<sub>26</sub></td><td>Pentagalloyl-hexoside II</td></tr><tr><td>7.</td><td align="char" char=".">5.08</td><td align="char" char=".">447.09439</td><td align="char" char=".">4.926</td><td>C<sub>21</sub>H<sub>19</sub>O<sub>11</sub></td><td>Kaempferol-3-<italic>O</italic>-galactoside</td></tr><tr><td>8.</td><td align="char" char=".">5.24</td><td align="char" char=".">317.03108</td><td align="char" char=".">5.950</td><td>C<sub>21</sub>H<sub>20</sub>O<sub>12</sub></td><td>Myricetin</td></tr><tr><td>9.</td><td align="char" char=".">5.39</td><td align="char" char=".">463.08957</td><td align="char" char=".">5.392</td><td>C<sub>15</sub>H<sub>9</sub>O<sub>8</sub></td><td>Quercetin-3-<italic>O</italic>-galactoside</td></tr><tr><td>10.</td><td align="char" char=".">6.14</td><td align="char" char=".">193.05037</td><td align="char" char=".">4.324</td><td>C<sub>10</sub>H<sub>9</sub>O<sub>4</sub></td><td>Isoferulic acid</td></tr><tr><td>11.</td><td align="char" char=".">6.96</td><td align="char" char=".">583.11093</td><td align="char" char=".">4.576</td><td>C<sub>28</sub>H<sub>23</sub>O<sub>14</sub></td><td>Afzelin-O-gallate</td></tr><tr><td>12.</td><td align="char" char=".">7.37</td><td align="char" char=".">301.03571</td><td align="char" char=".">4.753</td><td>C<sub>15</sub>H<sub>9</sub>O<sub>7</sub></td><td>Quercetin</td></tr><tr><td>13.</td><td align="char" char=".">7.44</td><td align="char" char=".">603.07947</td><td align="char" char=".">4.209</td><td>C<sub>30</sub>H<sub>19</sub>O<sub>14</sub></td><td>Quercetin dimer</td></tr><tr><td>14.</td><td align="char" char=".">7.69</td><td align="char" char=".">255.06647</td><td align="char" char=".">5.037</td><td>C<sub>15</sub>H<sub>11</sub>O<sub>4</sub></td><td>Pinocembrin (isomer 1)</td></tr><tr><td>15.</td><td align="char" char=".">8.12</td><td align="char" char=".">593.13110</td><td align="char" char=".">3.596</td><td>C<sub>30</sub>H<sub>25</sub>O<sub>13</sub></td><td>Kaempferol-3-<italic>O</italic>-glucoside</td></tr><tr><td>16.</td><td align="char" char=".">8.14</td><td align="char" char=".">315.05182</td><td align="char" char=".">6.002</td><td>C<sub>16</sub>H<sub>11</sub>O<sub>7</sub></td><td>Rhamnetin</td></tr><tr><td>17.</td><td align="char" char=".">8.57</td><td align="char" char=".">271.06100</td><td align="char" char=".">3.321</td><td>C<sub>15</sub>H<sub>12</sub>O<sub>5</sub></td><td>Pinobaksin</td></tr><tr><td>18.</td><td align="char" char=".">8.94</td><td align="char" char=".">285.04059</td><td align="char" char=".">4.299</td><td>C<sub>15</sub>H<sub>9</sub>O<sub>6</sub></td><td>Kaempferol</td></tr><tr><td>19.</td><td align="char" char=".">11.45</td><td align="char" char=".">255.06644</td><td align="char" char=".">4.919</td><td>C<sub>15</sub>H<sub>11</sub>O<sub>4</sub></td><td>Pinocembrin (isomer 2)</td></tr><tr><td>20.</td><td align="char" char=".">11.64</td><td align="char" char=".">253.05086</td><td align="char" char=".">5.235</td><td>C<sub>15</sub>H<sub>9</sub>O<sub>4</sub></td><td>Chyrsin</td></tr><tr><td>21.</td><td align="char" char=".">11.92</td><td align="char" char=".">299.05606</td><td align="char" char=".">3.496</td><td>C<sub>16</sub>H<sub>11</sub>O<sub>6</sub></td><td>Kaempferide I</td></tr><tr><td>22.</td><td align="char" char=".">12.12</td><td align="char" char=".">269.04529</td><td align="char" char=".">3.123</td><td>C<sub>15</sub>H<sub>9</sub>O<sub>5</sub></td><td>Genistein</td></tr><tr><td>23.</td><td align="char" char=".">12.39</td><td align="char" char=".">299.05649</td><td align="char" char=".">4.934</td><td>C<sub>16</sub>H<sub>11</sub>O<sub>6</sub></td><td>Kaempferide II</td></tr><tr><td>24.</td><td align="char" char=".">12.75</td><td align="char" char=".">313.07236</td><td align="char" char=".">5.415</td><td>C<sub>17</sub>H<sub>13</sub>O<sub>6</sub></td><td>Ermanin I</td></tr><tr><td>25.</td><td align="char" char=".">12.78</td><td align="char" char=".">313.07214</td><td align="char" char=".">4.713</td><td>C<sub>17</sub>H<sub>13</sub>O<sub>6</sub></td><td>Ermanin II</td></tr><tr><td>26.</td><td align="char" char=".">13.71</td><td align="char" char=".">269.08181</td><td align="char" char=".">3.771</td><td>C<sub>16</sub>H<sub>13</sub>O<sub>4</sub></td><td>Pinostrobin</td></tr></tbody></table></table-wrap></sec><sec id="s0027"><title>GC-MS analysis of MMCL &#x02013; identification of volatile compounds in MMCL</title><p>The GC-MS profile of MMCL is shown in <xref ref-type="fig" rid="F0003">Figure 3</xref>. Several peaks were detected with, at least eight identified to be (<bold>1</bold>) methanone, 6-phenanthridinylphenyl-, oxime, (E)- (retention time (<italic>R</italic><sub>T</sub>)&#x02009;=&#x02009;18.78&#x02009;min), (<bold>2</bold>) erucylamide/13-docosenamide, (Z) (<italic>R</italic><sub>T</sub>&#x02009;=&#x02009;19.74&#x02009;min), (<bold>3</bold>) 1,1&#x02032;:3&#x02032;,1&#x02033;-terphenyl-4&#x02032;,6&#x02032;-dimethoxy-2,2&#x02033;,3,3&#x02033;,5,5&#x02033;,6,6&#x02033;-octamethyl- (<italic>R</italic><sub>T</sub>&#x02009;=&#x02009;21.55&#x02009;min), (<bold>4</bold>) cholest-4-en-3-one, 2-hydroxy-, (2&#x003b1;)- (<italic>R</italic><sub>T</sub>&#x02009;=&#x02009;22.10&#x02009;min), (<bold>5</bold>) &#x003b1;-tocopherol (<italic>R</italic><sub>T</sub>&#x02009;=&#x02009;24.26&#x02009;min), (<bold>6</bold>) 2-(acetoxymethyl)-3-(methoxycarbonyl) biphenylene (<italic>R</italic><sub>T</sub>&#x02009;=&#x02009;28.64&#x02009;min), (<bold>7</bold>) 6-methyl-2-phenylindole (<italic>R</italic><sub>T</sub>&#x02009;=&#x02009;29.11&#x02009;min), and (<bold>8</bold>) 5-methyl-2-phenylindolizine (<italic>R</italic><sub>T</sub>&#x02009;=&#x02009;30.30&#x02009;min) (<xref rid="t0008" ref-type="table">Table 8</xref>).</p><fig id="F0003" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>GCMS profile of MMCL revealed the presence of several peaks. Eight of these peaks belong to volatile compounds namely (<bold>1</bold>) methanone, 6-phenanthridinylphenyl-, oxime, (<italic>E</italic>)- (retention time (<italic>R</italic><sub>T</sub>) = 18.78&#x02009;min), (<bold>2</bold>) erucylamide/13-docosenamide, (<italic>Z</italic>) (<italic>R</italic><sub>T</sub> = 19.74&#x02009;min), (<bold>3</bold>) 1,1&#x02032;:3&#x02032;,1&#x02033;-terphenyl-4&#x02032;,6&#x02032;-dimethoxy-2,2&#x02033;,3,3&#x02033;,5,5&#x02033;,6,6&#x02033;-octamethyl- (<italic>R</italic><sub>T</sub> = 21.55&#x02009;min), (<bold>4</bold>) cholest-4-en-3-one, 2-hydroxy-, (2&#x003b1;)- (<italic>R</italic><sub>T</sub> = 22.10&#x02009;min), (<bold>5</bold>) &#x003b1;-tocopherol (<italic>R</italic><sub>T</sub> = 24.26&#x02009;min), (<bold>6</bold>) 2-(acetoxymethyl)-3-(methoxycarbonyl) biphenylene (<italic>R</italic><sub>T</sub> = 28.64&#x02009;min), (<bold>7</bold>) 6-methyl-2-phenylindole (<italic>R</italic><sub>T</sub> = 29.11&#x02009;min), and (<bold>8</bold>) 5-methyl-2-phenylindolizine (<italic>R</italic><sub>T</sub> = 30.30&#x02009;min).</p></caption><graphic content-type="color" xlink:href="IPHB_A_1606836_F0003_C"/></fig><table-wrap id="t0008" orientation="portrait" position="float"><label>Table 8.</label><caption><p>GCMS analysis of MMCL.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">No. of peak</th><th align="center">Retention time (min)</th><th align="center">Name of the compound</th></tr></thead><tbody valign="top"><tr><td align="left">1</td><td align="char" char=".">18.783</td><td align="left">Methanone, 6-phenanthridinylphenyl-, oxime, (<italic>E</italic>)</td></tr><tr><td align="left">2</td><td align="char" char=".">19.738</td><td align="left">13-Docosenamide, (<italic>Z</italic>)</td></tr><tr><td align="left">3</td><td align="char" char=".">21.552</td><td align="left">1,1&#x02032;:3&#x02032;,1&#x02033;-Terphenyl, 4&#x02032;, 6&#x02032;-dimethoxy-2,2&#x02033;,3,3&#x02033;,5,5&#x02033;,6,6&#x02033;-octamethyl-</td></tr><tr><td align="left">4</td><td align="char" char=".">22.100</td><td align="left">Cholest-4-en-3-one, 2- hydroxy-, (2.alpha.)-</td></tr><tr><td align="left">5</td><td align="char" char=".">24.264</td><td align="left">Alpha-tocopherol</td></tr><tr><td align="left">6</td><td align="char" char=".">28.637</td><td align="left">2-(Acetoxymethyl)-3-(methoxycarbonyl)biphenylene</td></tr><tr><td align="left">7</td><td align="char" char=".">29.110</td><td align="left">6 Methyl-2 phenylindole</td></tr><tr><td align="left">8</td><td align="char" char=".">30.298</td><td align="left">5-Methyl-2-phenylindolizine</td></tr></tbody></table></table-wrap></sec></sec><sec id="s0028"><title>Discussion</title><p>The liver is primarily involved in detoxification and excretion of circulating compounds, which include toxic chemicals, as a mechanism in the preservation of health. Toxic chemicals are metabolized by the liver with subsequent release of liver tissue-damaging reactive oxygen species (ROS) or reactive nitrogen species (RNS) resulting in the leakage of liver enzymes into circulation. CCl<sub>4</sub>, classified as one of the volatile organic compounds (VOCs), is a lipophilic chemical and is highly toxic to the liver. Orally administered CCl<sub>4</sub> is extensively absorbed in the gastrointestinal tract and the systemic absorption occurs very rapidly (Kim et&#x000a0;al. <xref rid="CIT0010" ref-type="bibr">1990a</xref>). With regard to its mechanisms of toxicity, CCl<sub>4</sub> is metabolized in the endoplasmic reticulum via CYP2E1 to form highly reactive metabolites, the trichloromethyl and trichloromethyl peroxy free radicals. These free radicals, in the presence of oxygen, bind covalently to cellular macromolecules particularly the polyunsaturated fatty acids of the membrane phospholipids, triggering lipid peroxidation and disrupting mitochondrial, endoplasmic reticulum, and plasma membranes. The reaction results in loss of membrane integrity, glucose-6-phosphatase activation, cellular calcium sequestration and homeostasis, reduction of protein synthesis, and leakage of microsomal enzymes, which contribute to cell damage. Other by-products of lipid peroxidation, including reactive aldehydes, also cause hepatotoxicity (Weber et&#x000a0;al. <xref rid="CIT0029" ref-type="bibr">2003</xref>). In an attempt to assess the health risk inflicted by ingestion of CCl<sub>4</sub>-contaminated water, the previous toxicity studies use different types of digestible oils, as vehicle or diluent, to dissolve the volatile, lipophilic CCl<sub>4</sub> prior to its oral administration to animals due to its poor solubility in water (Kim et&#x000a0;al. <xref rid="CIT0011" ref-type="bibr">1990b</xref>). Once thought to be inert, vegetable oils in particular have been shown to produce physiological effects as well as to alter the absorption, target organ dose, and toxicity of CCl<sub>4</sub>. According to a study by Kim et&#x000a0;al. (<xref rid="CIT0010" ref-type="bibr">1990a</xref>), CCl<sub>4</sub> given orally in four different ways, namely (i) in corn oil; (ii) as an aqueous emulsion; (iii) as the pure, undiluted chemical; or (iv) in saturated water, exerts different pharmacokinetics potential. The blood CCl<sub>4</sub> concentration (<italic>C</italic><sub>max</sub>) of equivalent level reached its peak between 3.5 and 6&#x02009;min post-dosing when ingested as an aqueous emulsion or in water suggesting that the chemical is very rapidly and extensively absorbed from the gastrointestinal tract, and handled similarly by the body. These peak levels were higher than those in the undiluted CCl<sub>4</sub> group and significantly higher than those in the corn oil group suggesting that corn oil markedly delayed the absorption of CCl<sub>4</sub> from the gastrointestinal tract. Moreover, the higher bioavailability of CCl<sub>4</sub> in aqueous emulsion and in water indicated by the highest <italic>C</italic><sub>max</sub> with the shortest <italic>T</italic><sub>max</sub> correlates well with the degree of hepatotoxicity. Based on these observations, it was suggested that the use of aqueous vegetable oil emulsion is more suitable in acute hepatotoxicity studies of CCl<sub>4</sub> or other VOCs since the emulsion did not significantly alter the toxicity of CCl<sub>4</sub> in comparison to the undiluted CCl<sub>4</sub> or CCl<sub>4</sub> ingested in water. In addition, it is often essential to utilize the aqueous emulsion preparations to give toxicologically relevant doses in an aqueous dosage form, owing to the limited solubility of CCl<sub>4</sub> in water. Further studies carried out by Kim et&#x000a0;al. (<xref rid="CIT0011" ref-type="bibr">1990b</xref>) revealed the ability of dosing vehicles to extensively influence the acute hepatotoxic effect of CCl<sub>4</sub> in rats. Using CCl<sub>4</sub> in corn oil, in water, as an aqueous emulsion or in pure, undiluted form, the serum sorbitol dehydrogenase (SDH), glutamic-pyruvic transaminase (GPT), and ornithine carbamyl transferase (OCT) activities of the hepatotoxic liver were found to be elevated with the same time course, peaking at 48&#x02009;h and diminishing considerably by 72&#x02009;h. However, the serum enzyme activities in group that received CCl<sub>4</sub> in corn oil were the lowest in comparison with the other groups suggesting a less hepatotoxic effect resulting from a delayed/prolonged systemic absorption and bioavailability of CCl<sub>4</sub> caused by corn oil. The delayed/prolonged effects of corn oil on absorption and bioavailability of CCl<sub>4</sub> are attributed to the oil ability to reduce intragastric motility and delay gastric emptying by acting as a reservoir in the gut to retard the systemic absorption of lipophilic chemicals conceivably delaying uptake of CCl<sub>4</sub>. In the present study, CCl<sub>4</sub> was dissolved in 50% olive oil in water and was found to successfully induced hepatotoxicity when given orally to rats, thus, supported the previous reports that the emulsion-based vehicle did not significantly alter the pharmacokinetics or hepatotoxicity of CCl<sub>4</sub> (Kim et&#x000a0;al. <xref rid="CIT0010" ref-type="bibr">1990a</xref>, <xref rid="CIT0011" ref-type="bibr">1990b</xref>).</p><p>It is also worth-mentioning that the ability of a single dose of CCl<sub>4</sub> in 50% olive oil used in the present study to cause an abrupt increase in liver size, LW/BW ratio and increase in serum liver enzymes is in accordance with a previous report made by Uemitsu and Nakayoshi (<xref rid="CIT0028" ref-type="bibr">1984</xref>) and Kim et&#x000a0;al. (<xref rid="CIT0011" ref-type="bibr">1990b</xref>). These observations could be attributed to earlier finding that CCl<sub>4</sub> in aqueous emulsion was absorbed rapidly and extensively from the gastrointestinal tract (Kim et&#x000a0;al., <xref rid="CIT0010" ref-type="bibr">1990a</xref>) and reached its peak serum concentration (<italic>C</italic><sub>max</sub>) between 3.5 and 6&#x02009;min (shortest <italic>T</italic><sub>max</sub>) after dosing in comparison to CCl<sub>4</sub> dissolved in undiluted corn oil. Kim et&#x000a0;al. (<xref rid="CIT0010" ref-type="bibr">1990a</xref>) also cited earlier findings that absorption of radiolabeled CCl<sub>4</sub> (<sup>14</sup>CCl<sub>4</sub>) into liver lipids and proteins, and hepatic lipoperoxidation reached its maximum within 5&#x02013;90&#x02009;min of intragastric administration of CCl<sub>4</sub> to rats. Moreover, Kim et&#x000a0;al. (<xref rid="CIT0011" ref-type="bibr">1990b</xref>) also reported that the serum enzyme activities increase significantly 6&#x02009;h after CCl<sub>4</sub> dosing, reached peak concentration at 48&#x02009;h and diminished considerably by 72&#x02009;h. Based on this observations, it is plausible to suggest that during the first 6&#x02009;h after CCl<sub>4</sub> administration, the liver toxicity started to progress with maximum damage to the liver architecture at 48&#x02009;h, which was indicated by an increase in liver weight. This was the reason why in the study design the animals were sacrificed 48&#x02009;h after the administration of CCl<sub>4</sub>. Furthermore, the ability of CCl<sub>4</sub> in aqueous emulsion to successfully triggered liver damage when administered as a single dose treatment could also be attributed to the use of animal model that was particularly sensitive to CCl<sub>4</sub> hepatotoxicity. As cited by Kim et&#x000a0;al. (<xref rid="CIT0011" ref-type="bibr">1990b</xref>), the toxicity of CCl<sub>4</sub> can be influenced by the age/body weight of rats whereby rats with lower body weight (200&#x02013;250&#x02009;g) were more susceptible to acute CCl<sub>4</sub> hepatotoxicity than those weighing 300&#x02013;350&#x02009;g.</p><p>The liver is one of the organs most prone to damage caused by ROS and lipid peroxidation. Organisms have developed a sophisticated antioxidant system, primarily SOD and CAT, to protect the liver and maintain the redox homeostasis. However, excessive production of ROS can disrupt homeostasis and cause damage to the liver. MMCL was shown to possess remarkable antioxidant activities, primarily due its high content of phenolic compounds (Zakaria et&#x000a0;al. <xref rid="CIT0032" ref-type="bibr">2014</xref>). In the current study, pretreatment of MMCL appeared to protect the liver from developing CCl<sub>4</sub>-induced liver damage. This hepatoprotective property of MMCL is partly thorough stimulation of liver tissue SOD and CAT activities and subsequently clearance of the liver tissue-damaging ROS.</p><p>Among effects of CCl<sub>4</sub> on the liver is the initiation of inflammation in liver tissues. Like most tissues, liver inflammation manifest as release of inflammatory markers including NO, TNF-&#x003b1;, IL-1&#x003b2;, and IL-6. The markers are pro-inflammatory and mediate acute phase protein synthesis, lipid metabolism, cholestasis, and fibrosis (Sharma et&#x000a0;al. <xref rid="CIT0024" ref-type="bibr">2007</xref>; Niederreiter and Tilg, <xref rid="CIT0020" ref-type="bibr">2018</xref>). Although still controversial, the role of NO in liver has been associated with both beneficial and detrimental consequences. For example, NO exerts a protective role in mild oxidative hepatotoxicity models. Moreover, previous study has also suggested that the hepatoprotective effects of NO seen in the CCl<sub>4</sub>-induced model might be partly due to the inhibition of TNF-&#x003b1; (Morio et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2001</xref>), which together with IL-1&#x003b2; and IL-6 constitute part of pro-inflammatory cytokines (Kandil et&#x000a0;al. <xref rid="CIT0009" ref-type="bibr">2017</xref>). Various cytokine receptors, including those for TNF-&#x003b1;, IL-1&#x003b2;, and IL-6, can be found in normal hepatocytes and, upon chemical-induced injury to Kupffer cells, hepatic stellates, and sinusoid endothelial cells these pro-inflammatory cytokines are produce/release resulting in infiltration of neutrophils and monocytes into the damaged liver (Zhang et&#x000a0;al. <xref rid="CIT0034" ref-type="bibr">2004</xref>). In the present study, CCl<sub>4</sub> administration caused significant lower of liver NO concentration, but significantly increased the TNF-&#x003b1;, IL-1&#x003b2;, and IL-6 concentrations compared to normal. In rat with CCl<sub>4</sub>-induced hepatotoxicity, with MMCL pretreatment, the liver NO concentration increased and the TNF-&#x003b1;, IL-1&#x003b2;, and IL-6 concentrations decreased, suggesting that the extract have protective effects on liver from inflammation (Zakaria et&#x000a0;al. <xref rid="CIT0033" ref-type="bibr">2007</xref>). The hepatoprotective effect of MMCL, particular at high treatment concentration, was also evident in the liver histopathological results of the study. At 500&#x02009;mg/kg body weight MMCL, the treated rats did not develop the severe liver lesions seen in non-treated rats. These findings further supported previous claims that MMCL possesses anti-inflammatory activity (Zakaria et&#x000a0;al. <xref rid="CIT0033" ref-type="bibr">2007</xref>; Balan et&#x000a0;al. <xref rid="CIT0003" ref-type="bibr">2015</xref>).</p><p>In this study, we showed that the effect of MMCL in the amelioration of CCl<sub>4</sub>-induced hepatotoxicity is also reflected by the change in plasma liver enzymes. The plasma ALT, AST, and ALP concentrations increase following the CCl<sub>4</sub> administration, indicating hepatocellular damage and disruption of structural integrity of the liver. These observations could be directly attributed to the ability of CCl<sub>4</sub> to induce lipid peroxidation, which, in turn, caused hepatocytes membrane injury with subsequent necrosis as demonstrated in the histopathological analysis. Disruption of hepatocytes membrane integrity resulted in the dissolution of the cell contents, including the said enzymes, into blood circulation (Tolman and Dalpiaz <xref rid="CIT0025" ref-type="bibr">2013</xref>). Pretreatment with MMCL or NAC were able to reduce the ALT and AST, but not ALP levels supported the above connotation on the potential of MMCL to exert hepatoprotective effect. In the liver, ALT is localized solely in the cellular cytoplasm, whereas AST is found both in the cytosol and mitochondrial. Therefore, an increase in ALT is a more specific indicator for liver damage (Giannini et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2005</xref>). Although ALP is ubiquitous, found in various organs and cells of the body, including the liver, the source of plasma ALP, in this case, is presumably the liver. Moreover, the high level of ALP could also be attributed to its long half-life in the circulation (7&#x02009;d) in comparison with the transaminases [ALT (47&#x02009;h) and AST (17&#x02009;h)] leading to its slow decrease after resolution (Giannini et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2005</xref>).</p><p>UHPLC-ESI analysis showed that MMCL contained at least 26 flavonoid-based bioactive compounds. Of these, 22 bioactive compounds were detected in the ethyl acetate partition of MMCL (Zakaria et&#x000a0;al. <xref rid="CIT0030" ref-type="bibr">2016</xref>). Some of these compounds in MMCL, such as gallic acid, ferulic acid, quercetin, and genistein have been reported to protect the liver from CCl<sub>4</sub>-induced toxicity (Pavanato et&#x000a0;al. <xref rid="CIT0022" ref-type="bibr">2003</xref>; Kuzu et&#x000a0;al. <xref rid="CIT0013" ref-type="bibr">2007</xref>; Tung et&#x000a0;al. <xref rid="CIT0027" ref-type="bibr">2009</xref>; Kim et&#x000a0;al. <xref rid="CIT0012" ref-type="bibr">2011</xref>). Gallic acid, for example, downregulated CYP<sub>2</sub>E<sub>1</sub> expression in liver tissues while increasing SOD activities. These effects serve to modulate the antioxidant enzymes activities and inhibit lipid peroxidation. Ferulic acid, on the other hand, attenuates the serum of TNF-&#x003b1;, iNOS, and COX-2 mRNA expressions. Ferulic acid also attenuated cytosolic NF-&#x003ba;&#x003b2;, phosphorylated JNK, p38 mitogen-activated protein (MAP) kinase, and nuclear translocation of activated c-Jun, while decreasing the cytosolic concentrations of NF-&#x003ba;&#x003b2; inhibitors and TLR<sub>4</sub>. Thus, in CCl<sub>4</sub>-induced liver damage, the ferulic acid in MMCL reduces the adverse effects caused by oxidative radicals and inflammatory response. The hepatoprotective activity of quercetin is through the reduction of liver collagen content, iNOS expression, and lipid peroxidation, which are associated with an improved total peroxyl radical-trapping antioxidant capacity. Genistein can attenuate liver toxicity by inhibiting lipid peroxidation and stimulating antioxidation. In addition, genistein also exerts anti-inflammatory and antinecrotic effects, which further contributes to the attenuation of liver toxicity. It is, therefore, reasonable to assume that the hepatoprotective activities of MMCL is attributed to its gallic acid, ferulic acid, quercetin, and genistein components that most possibly act synergistically (Morio et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2001</xref>).</p></sec><sec id="s0029"><title>Conclusions</title><p>MMCL effectively prevent CCl<sub>4</sub>-induced liver toxicity in rats by attenuating lipid peroxidation, stimulating antioxidation through SOD and CAT, anti-inflammation through upregulation of NO and downregulation of TNF-&#x003b1;, IL-1&#x003b2;, and IL-6 activities. The hepatoprotective activities of MMCL are proposed to occur through the synergic effects of its chemical component, namely, gallic acid, ferulic acid, quercetin, and genistein.</p></sec></body><back><sec><title>Acknowledgements</title><p>The authors thanked the Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Malaysia for providing the facilities to carry out this research.</p></sec><sec id="s0030"><title>Disclosure statement</title><p>The authors report no declaration of interest.</p></sec><ref-list><title>References</title><ref id="CIT0001"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdul Rahim</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Zakaria</surname><given-names>ZA</given-names></name>, <name name-style="western"><surname>Mohd Sani</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Omar</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Yakob</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Cheema</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Ching</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Ahmad</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Abdul Kadir</surname><given-names>A</given-names></name></person-group>
<year>2016</year>
<article-title>Methanolic extract of <italic>Clinacanthus nutans</italic> exerts antinociceptive activity via the opioid/nitric oxide-mediated, but cGMP-independent, pathways</article-title>. <source>Evid-Based Complement Altern Med</source>. <volume>2016</volume>:<fpage>1494981</fpage>.</mixed-citation></ref><ref id="CIT0002"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balan</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mohd Sani</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Suppaiah</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Mohtarrudin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Suhaili</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Ahmad</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zakaria</surname><given-names>ZA</given-names></name></person-group>
<year>2014</year>
<article-title>Antiulcer activity of <italic>Muntingia calabura</italic> leaves involves the modulation of endogenous nitric oxide and nonprotein sulfhydryl compounds</article-title>. <source>Pharm Biol</source>. <volume>52</volume>:<fpage>410</fpage>&#x02013;<lpage>418</lpage>.</mixed-citation></ref><ref id="CIT0003"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balan</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sani</surname><given-names>MHM</given-names></name>, <name name-style="western"><surname>Mumtaz Ahmad</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Suppaiah</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Mohtarrudin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Zakaria</surname><given-names>ZA</given-names></name></person-group>
<year>2015</year>
<article-title>Antioxidant and anti-inflammatory activities contribute to the prophylactic effect of semi-purified fractions obtained from the crude methanol extract of <italic>Muntingia calabura</italic> leaves against gastric ulceration in rats</article-title>. <source>J Ethnopharmacol</source>. <volume>164</volume>:<fpage>1</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">25540923</pub-id></mixed-citation></ref><ref id="CIT0004"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bezenjani</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Pouraboli</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Afshar</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Mohammadi</surname><given-names>G</given-names></name></person-group>
<year>2012</year>
<article-title>Hepatoprotective effect of <italic>Otostegia persica</italic> Boiss. shoot extract on carbon tetrachloride-induced acute liver damage in rats</article-title>. <source>Iran J Pharm Res</source>. <volume>11</volume>:<fpage>1235</fpage>&#x02013;<lpage>1241</lpage>.<pub-id pub-id-type="pmid">24250558</pub-id></mixed-citation></ref><ref id="CIT0005"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boll</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Weber</surname><given-names>LW</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Stampfl</surname><given-names>A</given-names></name></person-group>
<year>2001</year>
<article-title>Mechanism of carbon tetrachloride-induced hepatotoxicity. Hepatocellular damage by reactive carbon tetrachloride metabolites</article-title>. <source>Zeitschrift Fur Naturforschung. C</source>. <volume>56</volume>:<fpage>649</fpage>&#x02013;<lpage>659</lpage>.</mixed-citation></ref><ref id="CIT0006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giannini</surname><given-names>EG</given-names></name>, <name name-style="western"><surname>Testa</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Savarino</surname><given-names>V</given-names></name></person-group>
<year>2005</year>
<article-title>Liver enzyme alteration: a guide for clinicians</article-title>. <source>CMAJ</source>. <volume>172</volume>:<fpage>367</fpage>&#x02013;<lpage>379</lpage>.<pub-id pub-id-type="pmid">15684121</pub-id></mixed-citation></ref><ref id="CIT0007"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heikal</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Mossa</surname><given-names>ATH</given-names></name>, <name name-style="western"><surname>Abdel Rasoul</surname><given-names>MAA</given-names></name>, <name name-style="western"><surname>Marei</surname><given-names>G</given-names></name></person-group>
<year>2013</year>
<article-title>The ameliorating effects of green tea extract against cyromazine and chlorpyrifos induced liver toxicity in male rats</article-title>. <source>Asian J Pharm Clin Res</source>. <volume>6</volume>:<fpage>48</fpage>&#x02013;<lpage>55</lpage>.</mixed-citation></ref><ref id="CIT0008"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamisan</surname><given-names>FH</given-names></name>, <name name-style="western"><surname>Yahya</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Mamat</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Kamarolzaman</surname><given-names>MFF</given-names></name>, <name name-style="western"><surname>Suhaili</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Mohtarrudin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Teh</surname><given-names>LK</given-names></name>, <name name-style="western"><surname>Salleh</surname><given-names>MZ</given-names></name>, <name name-style="western"><surname>Hussain</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Zakaria</surname><given-names>ZA</given-names></name></person-group>
<year>2014</year>
<article-title>Effect of methanol extract of <italic>Dicranopteris linearis</italic> against carbon tetrachloride-induced acute liver injury in rats</article-title>. <source>BMC Complement Alternat Med</source>. <volume>14</volume>:<fpage>123</fpage>&#x02013;<lpage>132</lpage>.</mixed-citation></ref><ref id="CIT0009"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kandil</surname><given-names>YI</given-names></name>, <name name-style="western"><surname>Maraqa</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Oriquat</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Shraideh</surname><given-names>ZA</given-names></name></person-group>
<year>2017</year>
<article-title>Resveratrol pretreatment reduces circulating inflammatory interleukins in CCl<sub>4</sub>-induced hepatotoxicity rats</article-title>. <source>Bull Fac Pharm Cairo Univ</source>. <volume>55</volume>:<fpage>319</fpage>&#x02013;<lpage>323</lpage>.</mixed-citation></ref><ref id="CIT0010"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Bruckner</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>Dallas</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Gallo</surname><given-names>JM</given-names></name></person-group>
<year>1990a</year>
<article-title>Effect of dosing vehicles on the pharmacokinetics of orally administered carbon tetrachloride in rats</article-title>. <source>Toxicol Appl Pharmacol</source>. <volume>102</volume>:<fpage>50</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">2296771</pub-id></mixed-citation></ref><ref id="CIT0011"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Odend&#x02019;hal</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bruckner</surname><given-names>JV</given-names></name></person-group>
<year>1990b</year>
<article-title>Effect of oral dosing vehicles on the acute hepatotoxicity of carbon tetrachloride in rats</article-title>. <source>Toxicol Appl Pharmacol</source>. <volume>102</volume>:<fpage>34</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="pmid">2296770</pub-id></mixed-citation></ref><ref id="CIT0012"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H-Y</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>J-H</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>K-H</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>D-U</given-names></name>, <name name-style="western"><surname>Kwak</surname><given-names>J-H</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>Y-S</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>S-M</given-names></name></person-group>
<year>2011</year>
<article-title>Ferulic acid protects against carbon tetrachloride-induced liver injury in mice</article-title>. <source>Toxicology</source>. <volume>282</volume>:<fpage>104</fpage>&#x02013;<lpage>111</lpage>.<pub-id pub-id-type="pmid">21291945</pub-id></mixed-citation></ref><ref id="CIT0013"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuzu</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Metin</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Dagli</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Akdemir</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Orhan</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Yalniz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ozercan</surname><given-names>IH</given-names></name>, <name name-style="western"><surname>Sahin</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bahcecioglu</surname><given-names>IH</given-names></name></person-group>
<year>2007</year>
<article-title>Protective role of genistein in acute liver damage induced by carbon tetrachloride</article-title>. <source>Mediat Inflamm</source>. <volume>2007</volume>:<fpage>36381</fpage>.</mixed-citation></ref><ref id="CIT0014"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Geng</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>Z</given-names></name></person-group>
<year>2016</year>
<article-title>The hepatoprotective effects of baicalein against CCl4-induced acute liver injury in mice</article-title>. <source>Int J Clin Exp Med</source>. <volume>9</volume>:<fpage>23206</fpage>&#x02013;<lpage>23213</lpage>.</mixed-citation></ref><ref id="CIT0015"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahmood</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Mamat</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Kamisan</surname><given-names>FH</given-names></name>, <name name-style="western"><surname>Yahya</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kamarolzaman</surname><given-names>MFF</given-names></name>, <name name-style="western"><surname>Nasir</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Suhaili</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Mohtarrudin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Zakaria</surname><given-names>ZA</given-names></name></person-group>
<year>2014b</year>
<article-title>Amelioration of paracetamol-induced hepatotoxicity in rat by the administration of methanol extract of <italic>Muntingia calabura</italic> L</article-title>. <source>leaves. Biomed Res Int</source>. <volume>2014</volume>:<fpage>695678</fpage>.<pub-id pub-id-type="pmid">24868543</pub-id></mixed-citation></ref><ref id="CIT0016"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahmood</surname><given-names>ND</given-names></name>, <name name-style="western"><surname>Nasir</surname><given-names>NLM</given-names></name>, <name name-style="western"><surname>Rofiee</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Tohid</surname><given-names>SFM</given-names></name>, <name name-style="western"><surname>Ching</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Teh</surname><given-names>LK</given-names></name>, <name name-style="western"><surname>Salleh</surname><given-names>MZ</given-names></name>, <name name-style="western"><surname>Zakaria</surname><given-names>ZA</given-names></name></person-group>
<year>2014</year>
<article-title><italic>Muntingia calabura</italic> L.: a review on its traditional uses, chemical properties and pharmacological observations</article-title>. <source>Pharm Biol</source>. <volume>52</volume>:<fpage>1598</fpage>&#x02013;<lpage>1623</lpage>.<pub-id pub-id-type="pmid">25068675</pub-id></mixed-citation></ref><ref id="CIT0017"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malyshev</surname><given-names>IY</given-names></name>, <name name-style="western"><surname>Shnyra</surname><given-names>A</given-names></name></person-group>
<year>2003</year>
<article-title>Controlled modulation of inflammatory, stress and apoptotic responses in macrophages</article-title>. <source>Current Drug Targets Immune, Endocr Metabolic Disord</source>. <volume>3</volume>:<fpage>1</fpage>&#x02013;<lpage>22</lpage>.</mixed-citation></ref><ref id="CIT0018"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manibusan</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Odin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Eastmond</surname><given-names>DA</given-names></name></person-group>
<year>2007</year>
<article-title>Postulated carbon tetrachloride mode of action: a review</article-title>. <source>J Environ Sci Health C Environ Carcinogen Ecotoxicol Rev</source>. <volume>25</volume>:<fpage>185</fpage>&#x02013;<lpage>209</lpage>.</mixed-citation></ref><ref id="CIT0019"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morio</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Chiu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sprowles</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Heck</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Gordon</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Laskin</surname><given-names>DL</given-names></name></person-group>
<year>2001</year>
<article-title>Distinct roles of tumor necrosis factor-alpha and nitric oxide in acute liver injury induced by carbon tetrachloride in mice</article-title>. <source>Toxicol Appl Pharmacol</source>. <volume>172</volume>:<fpage>44</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">11264022</pub-id></mixed-citation></ref><ref id="CIT0020"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niederreiter</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tilg</surname><given-names>H</given-names></name></person-group>
<year>2018</year>
<article-title>Cytokines and fatty liver diseases</article-title>. <source>Liver Res</source>. <volume>2</volume>:<fpage>14</fpage>&#x02013;<lpage>20</lpage>.</mixed-citation></ref><ref id="CIT0021"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohata</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ohashi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Matsura</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tokunaga</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kitagawa</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yamada</surname><given-names>K</given-names></name></person-group>
<year>2008</year>
<article-title>Octacosanol attenuates disrupted hepatic reactive oxygen species metabolism associated with acute liver injury progression in rats intoxicated with carbon tetrachloride</article-title>. <source>J Clin Biochem Nutr</source>. <volume>42</volume>:<fpage>118</fpage>&#x02013;<lpage>125</lpage>.<pub-id pub-id-type="pmid">18385828</pub-id></mixed-citation></ref><ref id="CIT0022"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pavanato</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tu&#x000f1;&#x000f3;n</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>S&#x000e1;nchez-Campos</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Marroni</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Llesuy</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gonz&#x000e1;lez-Gallego</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Marroni</surname><given-names>N</given-names></name></person-group>
<year>2003</year>
<article-title>Effects of quercetin on liver damage in rats with carbon tetrachloride-induced cirrhosis</article-title>. <source>Dig Dis Sci</source>. <volume>48</volume>:<fpage>824</fpage>&#x02013;<lpage>829</lpage>.<pub-id pub-id-type="pmid">12741479</pub-id></mixed-citation></ref><ref id="CIT0024"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Al-Omran</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Parvathy</surname><given-names>SS</given-names></name></person-group>
<year>2007</year>
<article-title>Role of nitric oxide in inflammatory disease</article-title>. <source>Inflammopharmacology</source>. <volume>15</volume>:<fpage>252</fpage>&#x02013;<lpage>259</lpage>.<pub-id pub-id-type="pmid">18236016</pub-id></mixed-citation></ref><ref id="CIT0025"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Tolman</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Dalpiaz</surname><given-names>AS</given-names></name></person-group>
<year>2013</year>
<chapter-title>Occupational and environmental hepatotoxicity</chapter-title> In: <person-group person-group-type="editor"><name name-style="western"><surname>Kaplowitz</surname><given-names>N</given-names></name>, <name name-style="western"><surname>DeLeve</surname><given-names>LD</given-names></name></person-group>, editors. <source>Drug-induced liver disease</source>. 3rd ed. <publisher-loc>Massachusetts</publisher-loc>: <publisher-name>Academic Press</publisher-name>; p. <fpage>659</fpage>&#x02013;<lpage>675</lpage>.</mixed-citation></ref><ref id="CIT0026"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tukappa</surname><given-names>NKA</given-names></name>, <name name-style="western"><surname>Londonkar</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Nayaka</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>C</given-names></name></person-group>
<year>2015</year>
<article-title>Cytotoxicity and hepatoprotective attributes of methanolic extract of <italic>Rumex vesicarius</italic> L</article-title>. <source>Biol Res</source>. <volume>48</volume>:<fpage>19</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">25857314</pub-id></mixed-citation></ref><ref id="CIT0027"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tung</surname><given-names>Y-T</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>J-H</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>C-C</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>H-C</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y-L</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>S-C</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>S-T</given-names></name></person-group>
<year>2009</year>
<article-title>Protective effect of <italic>Acacia confusa</italic> bark extract and its active compound gallic acid against carbon tetrachloride-induced chronic liver injury in rats</article-title>. <source>Food Chem Toxicol: Int J Published Br Ind Biol Res Assoc</source>. <volume>47</volume>:<fpage>1385</fpage>&#x02013;<lpage>1392</lpage>.</mixed-citation></ref><ref id="CIT0028"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uemitsu</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Nakayoshi</surname><given-names>H</given-names></name></person-group>
<year>1984</year>
<article-title>Evaluation of liver weight changes following a single oral administration of carbon tetrachloride in rats</article-title>. <source>Toxicol Appl Pharmacol</source>. <volume>75</volume>:<fpage>1</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">6464015</pub-id></mixed-citation></ref><ref id="CIT0029"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weber</surname><given-names>LW</given-names></name>, <name name-style="western"><surname>Boll</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Stampfl</surname><given-names>A</given-names></name></person-group>
<year>2003</year>
<article-title>Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model</article-title>. <source>Crit Rev Toxicol</source>. <volume>33</volume>:<fpage>105</fpage>&#x02013;<lpage>136</lpage>.<pub-id pub-id-type="pmid">12708612</pub-id></mixed-citation></ref><ref id="CIT0030"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zakaria</surname><given-names>ZA</given-names></name>, <name name-style="western"><surname>Balan</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Azemi</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Omar</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Mohtarrudin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Zuraini</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Abdullah</surname><given-names>MNH</given-names></name>, <name name-style="western"><surname>Teh</surname><given-names>LK</given-names></name>, <name name-style="western"><surname>Salleh</surname><given-names>MZ</given-names></name></person-group>
<year>2016</year>
<article-title>Mechanism(s) of action underlying the gastroprotective effect of ethyl acetate fraction obtained from the crude methanolic leaves extract of <italic>Muntingia calabura</italic></article-title>. <source>BMC Complement Alternat Med</source>. <volume>16</volume>:<fpage>78</fpage>&#x02013;<lpage>94</lpage>.</mixed-citation></ref><ref id="CIT0031"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zakaria</surname><given-names>ZA</given-names></name>, <name name-style="western"><surname>Balan</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mamat</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Mohtarrudin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Teh</surname><given-names>LK</given-names></name>, <name name-style="western"><surname>Salleh</surname><given-names>MZ</given-names></name></person-group>
<year>2015</year>
<article-title>Mechanisms of gastroprotection of methanol extract of <italic>Melastoma malabathricum</italic> leaves</article-title>. <source>BMC Complement Alternat Med</source>. <volume>15</volume>:<fpage>135</fpage>&#x02013;<lpage>149</lpage>.</mixed-citation></ref><ref id="CIT0032"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zakaria</surname><given-names>ZA</given-names></name>, <name name-style="western"><surname>Balan</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Suppaiah</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Ahmad</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jamaludin</surname><given-names>F</given-names></name></person-group>
<year>2014</year>
<article-title>Mechanism(s) of action involved in the gastroprotective activity of <italic>Muntingia calabura</italic></article-title>. <source>J Ethnopharmacol</source>. <volume>151</volume>:<fpage>1184</fpage>&#x02013;<lpage>1193</lpage>.<pub-id pub-id-type="pmid">24380736</pub-id></mixed-citation></ref><ref id="CIT0033"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zakaria</surname><given-names>ZA</given-names></name>, <name name-style="western"><surname>Mohd. Nor Hazalin</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Mohd. Zaid</surname><given-names>SNH</given-names></name>, <name name-style="western"><surname>Abd. Ghani</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hassan</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Hanan Kumar</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sulaiman</surname><given-names>MR</given-names></name></person-group>
<year>2007</year>
<article-title>Antinociceptive, anti-inflammatory and antipyretic effects of <italic>Muntingia calabura</italic> aqueous extract in animal models</article-title>. <source>J Nat Med</source>. <volume>61</volume>:<fpage>443</fpage>&#x02013;<lpage>448</lpage>.</mixed-citation></ref><ref id="CIT0034"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>ZX</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>XZ</given-names></name></person-group>
<year>2004</year>
<article-title>Effects of cytokines on carbon tetrachloride-induced hepatic fibrogenesis in rats</article-title>. <source>World J Gastroenterol</source>. <volume>10</volume>:<fpage>77</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="pmid">14695773</pub-id></mixed-citation></ref><ref id="CIT0035"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name></person-group>
<year>2017</year>
<article-title>Seabuckthorn berry polysaccharide protects against carbon tetrachloride-induced hepatotoxicity in mice <italic>via</italic> anti-oxidative and anti-inflammatory activities</article-title>. <source>Food Funct</source>. <volume>8</volume>:<fpage>3130</fpage>&#x02013;<lpage>3138</lpage>.<pub-id pub-id-type="pmid">28766672</pub-id></mixed-citation></ref></ref-list></back></article>